StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Net cash inflow before financing activities by Quarter

Net cash inflow before financing activities ($M) ($M)

QuarterlyAnnual

AstraZeneca Net cash inflow before financing activities: -$47M in Q2 2026, down 103.7% from a year earlier. That is the lowest of the 18 quarters on record here.

Latest, Q2 2026
-47
Period ended Jun 30, 2026
Change on a year earlier
-103.7%
1,278 in Q2 2025
History
18 quarters
Since Q1 2021
Sources
18
Documents cited below

Where the Q2 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Condensed Cash Flow Statement.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet cash inflow before financing activities ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026-47-103.7%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20261,567-36.3%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025896-48.1%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20253,133+67.6%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20251,278+500.0%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20252,460+3,269.9%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20241,726+32.5%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20241,869-1.3%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024213-82.2%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202473-96.1%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20231,303–Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20231,893–Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20231,198+167.4%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20231,887-38.4%Form 6-K FY2023Q1 Earnings Release ↗
Q2 2022Jun 30, 2022448-31.7%Form 6-K FY2022Q2 Earnings Release ↗
Q1 2022Mar 31, 20223,064+23.1%Form 6-K FY2022Q1 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Net cash inflow before financing activities ($M), quarterly Q1 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/cf-before-financing

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.